Related Experiment Video
Updated: Jul 6, 2026

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
Published on: March 15, 2018
Osteoporotic bone formation in mice lacking tob2; involvement of Tob2 in RANK ligand expression and osteoclasts
Rieko Ajima1, Toru Akiyama, Michihiko Usui
1The Institute of Medical Science, University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.
Abstract:
Mice lacking tob2, a member of the antiproliferative family genes, had decreased bone mass, and the number of osteoclasts differentiated from bone marrow cells was increased. Overexpression of Tob2 in stromal cells repressed vitamin D(3)-induced osteoclasts formation. Furthermore, expression of RANKL mRNA in stromal cells was increased in the absence of Tob2 and decreased in the presence of Tob2. Tob2 interacted with vitamin D(3) receptor (VDR), which suggests its involvement in vitamin D(3) receptor-mediated regulation of transcription. Because VDR regulates RANKL expression, our data suggest that Tob2 negatively regulates formation of osteoclasts by suppressing RANKL expression through its interaction with VDR.
Insights
The antiproliferative gene Tob2 negatively regulates bone loss by suppressing osteoclast formation. Tob2 interacts with the vitamin D receptor to control RANKL expression, impacting bone mass.
Area of Science:
- Bone Biology
- Cellular and Molecular Biology
- Gene Regulation
Background:
- Tob2 is a member of the antiproliferative gene family.
- Osteoclasts play a critical role in bone resorption and bone mass regulation.
- Vitamin D receptor (VDR) signaling influences bone metabolism, including osteoclastogenesis.
Purpose of the Study:
- To investigate the role of Tob2 in bone metabolism and osteoclast formation.
- To elucidate the molecular mechanism by which Tob2 regulates osteoclastogenesis.
- To determine the interaction between Tob2 and the vitamin D receptor (VDR) in regulating RANKL expression.
Main Methods:
- Analysis of bone mass and osteoclast number in mice lacking Tob2.
- Overexpression of Tob2 in stromal cells to assess its effect on osteoclast formation.
- Measurement of RANKL mRNA expression in stromal cells under different Tob2 conditions.
- Investigation of the interaction between Tob2 and VDR using co-immunoprecipitation or similar techniques.
Main Results:
- Mice lacking Tob2 exhibited decreased bone mass and increased osteoclast numbers.
- Overexpression of Tob2 in stromal cells suppressed vitamin D(3)-induced osteoclast formation.
- RANKL mRNA expression was elevated in Tob2-deficient stromal cells and reduced when Tob2 was present.
- Tob2 was found to interact with the vitamin D receptor (VDR).
Conclusions:
- Tob2 negatively regulates osteoclast formation, thereby influencing bone mass.
- Tob2 suppresses RANKL expression through its interaction with VDR.
- This interaction suggests Tob2 is involved in VDR-mediated transcriptional regulation impacting bone homeostasis.
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Remodeling
Bone Formation by Intramembranous Ossification
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Formation by Endochondral Ossification
Bone Remodeling and Repair

